Wealth Enhancement Advisory Services
RPRX icon

Wealth Enhancement Advisory Services’s Royalty Pharma RPRX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Sell
38,713
-150,333
-80% -$6.58M ﹤0.01% 1424
2025
Q4 		$7.68M Buy
189,046
+165,451
+701% +$6.31M 0.01% 804
2025
Q3 		$852K Buy
23,595
+3,394
+17% +$123K ﹤0.01% 1969
2025
Q2 		$735K Buy
20,201
+3,841
+23% +$127K ﹤0.01% 1931
2025
Q1 		$509K Buy
16,360
+6,700
+69% +$212K ﹤0.01% 2059
2024
Q4 		$246K Buy
+9,660
New +$256K ﹤0.01% 2538
2024
Q2 		– Sell
-7,197
Closed -$219K – 2690
2024
Q1 		$219K Buy
+7,197
New +$212K ﹤0.01% 2132

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return